tradingkey.logo

BRIEF-Patients In The US Undergo First Doses Of GE Healthcare’S New Pet Radiotracer, Flyrcado Injection

ReutersFeb 25, 2025 2:42 PM

- GE Healthcare Technologies Inc GEHC.O:

  • PATIENTS IN THE US UNDERGO FIRST DOSES OF GE HEALTHCARE’S NEW PET RADIOTRACER, FLYRCADO (FLURPIRIDAZ F 18) INJECTION

  • GE HEALTHCARE TECHNOLOGIES INC - FLYRCADO EXPECTED TO BE AVAILABLE AT MOST CARDIAC PET CENTERS BY 2025

  • GE HEALTHCARE TECHNOLOGIES INC - FULL COMMERCIALIZATION OF FLYRCADO ANTICIPATED IN Q2 2025

Source text: ID:nBw6WSqfsa

Further company coverage: GEHC.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI